NK1-antagonist combination and method for treating synucleinopathies

• 收藏
• 分享

专利权人:

Chase Therapeutics Corporation

发明人:

Chase, Thomas N.,Clarence-Smith, Kathleen E.

申请号：

AU2018251604

公开号：

AU2018251604A1

申请日:

2018.04.09

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present invention describes the use of a NK1-antagonist, in combination with 6- propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine, to facilitate the treatment of a patient suffering from a synucleinopathy by enabling a therapeutically effective 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine daily dose to act without the typical adverse effects caused by pramipexole dihydrochloride monohydrate when administered alone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/